TAMARA SAIMONS: Open Payments
NPI 1538542873 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 17 payments from 4 companies in 2025. Trend: 2023 $927 · 2024 $744 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $258 |
| ViiV Healthcare Company | 2 | $77 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: PIFELTRO, DOVATO, Biktarvy, CABENUVA, Epclusa, SHINGRIX, BEXSERO.
Industry payments across NM — which companies pay providers there.
